SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (97)9/14/1997 11:07:00 PM
From: Czechsinthemail   of 496
 
Neuro,

Thanks for the follow-up. I didn't mean to imply criticism of insiders or to suggest anything was amiss in their selling. I think the company's prospects are very strong. But profit-taking at this point, particularly given the uncertainties of the stock market and the biotech market in particular, should not come as a surprise-- not only from company insiders but outside investors as well. I would view any pullbacks as buying opportunities.

Do you have more information on the details of the Taxol polymer delivery program? If RPR does not pick up their option, does it revert to Guilford entirely?

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News